NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors-Reference-Cited by-同舟云学术

NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors

Published:2021-12 Issue: Volume:159 Page:113-124
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Thielmann Carl M.^ORCID,Chorti Eleftheria,Matull Johanna,Murali Rajmohan,Zaremba Anne,Lodde Georg^ORCID,Jansen Philipp,Richter Luisa,Kretz Julia,Möller Inga,Sucker Antje^ORCID,Herbst Rudolf^ORCID,Terheyden Patrick,Utikal Jochen,Pföhler Claudia,Ulrich Jens,Kreuter Alexander^ORCID,Mohr Peter^ORCID,Gutzmer Ralf^ORCID,Meier Friedegund^ORCID,Dippel Edgar,Weichenthal Michael,Paschen Annette,Livingstone Elisabeth^ORCID,Zimmer Lisa^ORCID,Schadendorf Dirk,Hadaschik Eva^ORCID,Ugurel Selma,Griewank Klaus G.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Evolving treatment options for melanoma brain metastases;Ajithkumar;Lancet Oncol,2015

2. Melanoma;Schadendorf;Lancet,2018

3. Survival of patients with advanced metastatic melanoma: the impact of MAP kinase pathway inhibition and immune checkpoint inhibition - update 2019;Ugurel;Eur J Cancer,2020

4. Distinct sets of genetic alterations in melanoma;Curtin;N Engl J Med,2005

5. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma;Krauthammer;Nat Genet,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma;Pharmacogenomics and Personalized Medicine;2024-09

2. Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas;European Journal of Cancer;2024-09

3. Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma;Frontiers in Immunology;2024-06-05

4. Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations;International Journal of Molecular Sciences;2024-05-26

5. Development of Personalized Strategies for Precisely Battling Malignant Melanoma;International Journal of Molecular Sciences;2024-05-04